Servier laboratories compensated 3,593 patients up to 114.7 million euros following health problems caused by taking Mediator, an antidiabetic drug withdrawn from the market in 2009.
While the Servier laboratory will appear in criminal court on September 23, he affirms on his website to have, to March 29, already compensated 3,593 patients up to 114.7 million euros following heart problems caused by taking the Mediator. Record compensation in France in the medical field.
Specifically, 326 compensation offers are still awaiting a response from patients (the bill could then rise to 141.3 million euros) and 141 have refused it. The compensated victims have undertaken not to testify against Servier, who will be tried for “deception on the risks of the product”, “fraud”, and “homicides and intentional injuries”. According to Parisiansome patients received only a few thousand euros, but others hundreds of thousands of euros, up to 1 million euros.
“It is undeniable that patients have suffered from adverse effects”
As a reminder, the Mediator was an antidiabetic. Prescribed to more than 5 million people for 30 years, it has caused hundreds of deaths and has not been marketed since 2009. Revealed in 2010 by pulmonologist Irène Frachon with the release of her book Mediator 150 mg : how many deaths?this health scandal is the subject of several civil and criminal proceedings.
“We made, in 2011, the commitment to compensate the victims, without waiting for the outcome of the legal proceedings”, indicated to the Parisian Laurent Boussu, head of Servier’s compensation unit, who admits “it is undeniable that patients have suffered adverse effects related to taking Mediator. We reiterate our sincere regrets to the patients affected by this tragedy and to their family”.
.
